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Introduction
A significant discovery came about in 1975
because of two observant housewives. One of
them, a physician's wife, noticed a tendency
towards the diagnosis of juvenile rheumatoid
arthritis within her community. She knew that this
disease did not normally occur in clusters and
decided to report the observation to the State
Health Department. The other housewife report-
ed the unusual occurrence of arthritis occurring
from young to old in four of her family members.
Dr. Allen Steere, M.D., and co-workers decided
to investigate their reports. They discovered that
within three villages of Connecticut - Lyme, Old
Lyme, and East Haddam - a high frequency of
arthritis was reponed. The high frequency suggest-
ed that some infectious agent was involved. They
also noticed that the majority of cases occurred in
the summer or early fall. This seasonal tendency
implied involvement of an arthropod vector. At
that time, not much more was learned about the
disease. However, because of its geographic
tendency, the disease was appropriately named
Lyme Oisese (LD).1
Etiologic Agent
The etiologic agent of LD was not discovered
until 1982. At that time, Dr. Willy Burgdorfer
found strong evidence to indicate that a spirochete
causes LD and that the disease was spread by an
arthropod vector. In his studies, the guanine-plus-
cytosine content from isolates of the organisms
isolated from the vectors and the blood, spinal
fluid, and skin of human patients fit into the
category of a Borre/ia species. However, the ONA
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homology index was higher than that of other
Borre/ia. Since this spirochete did not fit into any
species category of Borre/ia, it was named after its
founder, and came to be known as Borre/ia
burgdorfen·. 2
Vector
The theory originating in 1975 that LO is trans-
mitted primarily by an arthropod vector has been
confirmed. The main arthropod involved appears
to be Ixodid ticks, however, the species of ticks
that transmits the diesease may vary with the
geographical location. For instance, in the North-
eastern states (Connecticut, Delaware, Maryland,
Massachusetts, New York, New Jersey, Pennsyl-
vania, and Rhode Island) and Midwestern states
(Minnesota and Wisconsin), Ixodes dammini is the
primary vector. In the Western United States
(California, Oregon, Nevada, and Utah) Ixodes
pacificus is the tick that transmits the agent of LO.
In Europe, USSR, and Scandinavia, Ixodes n'cinus
is the vector involved. 3 Recently, a report claims
that Ixodes persu/catus transmits LO in ]apan.4
Lyme disease may also occur outside the normal
recognized habitat of these ticks. There have been
reports of LD occurring in Arkansas, Florida,
Georgia, Kentucky, Indiana, Ohio, Montana,
North Carolina, Vermont, Tennessee, Texas,
Virginia, and Iowa. 5,6 Some investigators have
suggested that birds, which may be parasitized by
some Ixodes ticks, may carry ticks outside their
normal habitat. Other researchers isolated B. burg-
dorfen' from ticks such as Amb/yoma amen'cum,
Dermacenter vanabzfi, and 1. scapu/ans. 2 ,4,5,6 It
may also be possible that horse flies, deerflies, or
mosquitos act as secondary vectors of this disease.
Another interesting possible means of trans-
mission was discovered when researchers studied
deer mice (Peromyscus manicy/atus) and found
B. burgdorfen' in their urine. It was determined
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that mice could be infected by ingestion of infect-
ed urine. In this way, it was hypothesized that
contaminated feedstuffs could transmit the
disease. s
Despite these possible modes of transmission,
the Ixodes tick is known to be a primary vector of
LD. Therefore, the incidence and occurrence of the
disease relies heavily on the propagation, life cycle,
and distribution of this tick.
The Ixodes tick has a two-year cycle. In late
winter and early spring the tick deposits its eggs.
In late summer the larvae emerge and seek a blood
meal from their preferred host, the mouse. The
following spring, the larvae transform into
nymphs, which feed on blood from a mouse or
other available mammal. In late fall the nymphs
become adults and usually feed on deer, their
desired host. The female mates with the male and
then engorges herself with blood, drops to the
ground, discharges her eggs, and dies.
The tick can become infected with B. burgo-
dorfen' by feeding on an infected host at any point
in this cycle. It can then transmit the disease to
other animals when it feeds on them. The most
common time for the tick to transmit the disease
to humans or animals is during the nymph stage,2
Ticks can also be infected with the agent of dis-
ease by transovarial transmission. This has been
shown to occur with 1. n'cinus but has not been
proven with other species. 3
Incidence
Since 1975, there have been reports of LD in
32 states as well as Europe, Australia, USSR,
Ireland and ]apan,3,4,9-12 Within the U.S. there
have been over 6,000 reported cases since 1980. 13
The Center for Disease Control (CDC) suspects
that the number of cases is probably higher,
because physicians are just starting to become
aware of the disease. 14 Most of the available
statistical data is from cases involving humans.
However, the disease does affect other species.
LD has been reported in raccoons (Procyon loter),
white-tailed deer (Odocoileus virginanus), opossums
(Didelphis virginiana), eastern chipmunks (Tamias
stnatus), gray squirrels (Sciurus carolinensis), white-
footed mice (Peromyscus leucopus), rabbits,
passerine birds, dogs, horses, and cattle. 15-20
Lyme Disease in Humans
Lyme disease in humans is a multisystemic
complex disorder that can result in dermatologic,
neurologic, cardiac and joint abnormalities. The
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clinical syndrome has been divided into three
stages. The first stage involves the development
of an annular erythematous macule or papule at
the tick bite site, often with an area of central
clearing. This lesion, referred to as erythema
chronicum migrans (ECM), is regarded as the
hallmark sign ofLD in humans. According to the
Minnesota Health Department, ECM is present in
70 percent of the LD cases. 14 Other symptoms
which mayor may not occur with ECM include
fever, muscle aches, headache, stiff neck, lethargy
and sore joints. These symptoms can be accom-
panied by " ...high erythrocyte sedimentation rate
and total serum IgM titer, cryoglobulinemia,
abnormal CI-1 binding activity and circulating
immune complexes in both blood and spinal
fluid. "2
The second stage of the disease involves neuro-
logic and cardiac abnormalities. Usually within
weeks to months after onset of the first stage signs,
neurologic signs such as meningitis, cranial and
peripheral neuropathies, can develop. Some inves-
tigators feel that the signs closely resemble
Alzheimer's disease and multiple sclerosis. 21 The
cardiac sequelae, including lymphoplasmacytic
interstitial myocarditis, are characterized by varying
degrees of heart block that typically resolve within
one to six weeks. 2
The third and final stage presents as arthritis.
Although it is possible to see arthritis in the earlier
stages of LD, it is not usually clinically apparent
until several months after onset of the disease. This
part of the disease can be confused with other
causes of arthritis such as systemic lupus erythema-
tosis, rheumatoid arthritis, trauma, or other
infectious agents. 2
Recently, concern about Lyme disease and
pregnancy has been brought to the attention of
the Center for Disease Control (CDC). A 1986
study showed that' 'of the 19 pregnancies, five had
adverse outcomes, including syndactyly, cortical
blindness, intrauterine fetal death, prematurity
and rash in the newborn" .22 These problems
occurred when women were infected during
various stages of their pregnancy, however this
study could not directly link these problems to the
B. burgdorfen' infection. Despite this, officials
advise pregnant women not to take any chances
and visit their physicians if they have signs con-
sistent with LD. 23
Diagnosis
LD may be suspected in humans with the
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clinical signs discussed above and a history of pos-
sible exposure. Confirmation of LD is based upon
direct and indirect observation of the etiologic
agent, culture and identification of the etiologic
agent and serologic tests.
Microscopic examination of cenain samples may
potentially provide a rapid diagnosis. The
spirochete may be seen in synovial fluid, blood,
CFS, or ocular fluid samples when direct dark field
microscopy is used. The organism may also be
identified when tissue specimens stained with
aniline dyes or silverstains are microscopically
examined. Direct fluorescent antibody techniques
have been used on tissue specimens in an effort
to enhance detection. However, the success rate
of diagnosis using these direct methods is low; a
negative icsult does not rule out the possibility of
disease. 3
The organism can be cultured using Modified
Kelly's medium. Growth requires a microaerophilic
environment for up to eight weeks, and the
medium should be checked weekly for the presence
of spirochetes. This is a low yield process and the
medium is costly and difficult to prepare. The
process is also labor intensive making it impractical
for the practitioner. 24 Current research, directed
at developing a test to detect B. burgdorferi in the
urine, may enable the practitioner to obtain a rapid
diagnosis. 14
Presently, serology is the major diagnostic tool
used to diagnose LD. There are two techniques
currently used to detect serum antibodies to B.
burgdorferi: indirect fluorescent antibody (IFA)
and enzyme-linked immunosorbent assay (ELISA).
Positive results for the IFA are titers greater than
or equal to 1: 62 and positive results for the ELISA
are greater than or equal to 1: 160. 25 ,26 The CDC
claims that both of these tests are " ... equally
sensitive in their ability to reveal half of all cases
of Lyme Disease in its early stages and essentially
all late complicated cases."2 Some reports claim
that the ELISA is slightly more sensitive. This, plus
the fact that the test is objective and can be
automated, makes the ELISA technique more
desirable. 25 ,26
There are basically two drawbacks in the use of
the serologic methods for diagnosis. First, false
positives have resulted in humans with yaws, pinta,
and syphilis. 2 Secondly, LD in its early stages
cannot be consistently detected serologically.
Antibody titers to B. burgdorferi are not detect-
able serologically until one or two weeks post-
infection, since it takes that long for the body to
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start producing IgM. The IgM levels usually peak
around the third to sixth week and may persist for
months or years after the disease onset. IgG levels
tend to rise more slowly and are not detectable
until the fourth to sixth week of the disease. IgG
levels are highest months to years after infection
and may remain elevated for years after clinical
remission. 27 Since the IgG and IgM levels rise
slowly, early diagnosis of LD is based on clinical
signs and response to therapy.
Treatment
Cenain antibiotics have been found to be highly
effective in the treatment of LD. Tetracycline,
penicillin, and erythromycin are the most useful
drugs. 9,14,28 A recent article also describes
another dnlg; ceftriaxone; as being effective as a
treatment for LD.14 If the disease is recognized
early, oral antibiotics are effective. However,
prolonged oral therapy or intravenous therapy may
be indicated if the disease is not recognized until
the later stages.
Prevention
Prevention of this disease involves common
sense. Endemic or tick infested areas should be
avoided whenever possible. If not, protective cloth-
ing and tick repellent may prevent exposure. If any
clinical signs of LD are present, a physician should
be consulted. 9,23,29
Lyme Disease in Dogs
Lyme disease in dogs does not appear to have
three distinct stages as it does in humans. To date,
there have been no reports of ECM in dogs. This
may suggest that the lesion does not occur or that
owners do not see the lesion because of the
animal's hair coat. There also have been no reports
of neurologic problems directly associated with LD,
however, myocarditis similar to that seen in human
Lyme carditis, has been recently reported. 30
The major clinical sign seen with LD in dogs
appears to be arthritis. 31 ,32 In a recent study
performed by Magnarelli et al., 271 dogs were ex-
amined that were suspected of having borreliosis. 31
In this study, 91 percent showed signs of lameness,
53 percent were anorexic, 44 percent has fever, 29
percent showed signs of fatigue, 5 percent has
lymphadenopathy, and 2 percent of the dogs
experienced renal impairment. Males and females
appeared to be equally affected. Lameness was
often intermittent, affecting the carpal, digital,
tarsal, elbow, shoulder, stifle, cervical or lumbar
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regions. Serologic conformation of borreliosis was
made in 68 percent of the 243 lame dogs.
However, 78 dogs clinically diagnosed as having
LD were seronegative.
Diagnosis
This fairly high incidence of seronegative
animals in clinically diagnosed dogs brings about
an important point. All other differential diag-
noses need to be ruled out before a definitive
diagnosis of LD can be made. Differential diag-
noses would include degenerative joint disease,
septic arthritis, trauma, rheumatoid arthritis, and
systemic lupus erythematosus (SLE).32 Physical
examination, laboratory findings and radiography
should rule-out trauma or degenerative joint
disease. Giemsa stains and culture of synovial fluid
will help rule out septic arthritis. Systemic lupus
erythematosus is usually associated with other
organ involvement. Antinuclear antibodies or LE
cells can be detected in SLE. For rheumatoid
arthritis, radiographs, arthrocentesis and cytology,
and rheumatoid factor may aid in diagnosis.
Direct methods of diagnosis, such as dark field
microscopy and culture, are infrequently diag-
nostic. Measurements of serum antibodies to
Borrelia burdorfen' using ELISA or IFA techniques
are the best methods available to reach a definitive
diagnosis. Antibody titers rise slowly from onset
of infection. In the dog, IgM levels peak at about
one month; IgG levels rise more slowly but persist
for months. By the time arthritis develops IgG
levels are generally detectable. 15 In the dog, there
seems to be no problem with cross reaction to
Leptospira. 33
Treatment and Prevention
Little research has been done with respect to
treatment of animals with LD. Tetracycline,
penicillin, and erythromycin are effective in
humans, and these drugs are currently being used
with success in dogs as well. 15
As with humans, precautions should be taken
when a dog is in a tick infested area. Tick collars
and powders may be useful. When a dog has spent
time outside, it should be checked carefully for
ticks.
Lyme Disease in Horses
Lyme disease has recently been reported to occur
in horses in endemic areas. Reports have been less
common than in man or dogs but similar clinical
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signs are associated with the disease. Positive titers
(greater than 1:64) have been found in both clin-
ically normal horses and in horses with signs
attributed to the disease. 16,17 Survey reports from
endemic areas found 24-36 DID of general horse
population to have positive titers. 34
Nine clinical cases were identified in Connec-
ticut with signs including arthralgia, lameness,
laminitis and myalgia and with positive titers
ranging from 1:64 to 1: 1024.34 Eight of these were
treated with antibiotics and phenylbutazone and
all recovered. An equine clinician in Lyme,
Connecticut reports seing approximately 12 clinical
cases of LD per 1,000 horses per year (1.2 DID ).34
Diagnosis
Diagnosis of LD in horses is largely based on
clinical signs ruling out other diseases and response
to antibiotic therapy. The clinical signs reported
in horses include lethargy, low grade fever, mul-
tiple swollen painful joints, stiffness and reluctance
to move, laminitis, skin hypersensitivity and
myalgia, uveitis and various central nervous system
signs, suggestive of encephalitis. 16,36 The classic
ECM lesion of humans has not been reported in
horses although areas of hair loss and flaky skin
around suspected tick bites may occur.
Several procedures are useful in the diagnosis
of LD. In cases of arthritis, septic or traumatic
causes should be ruled out with radiographs and
synovial fluid analysis. A predominance of lym-
phocytes, plasma cells and villous proliferation are
the common joint characteristics reported in horses
with LD. When anterior uveitis is present, LD
must be differentiated from disease such as
onchocerciases or leptospirosis. With signs of
encephalitis, various viral encephalitides, protozoal
myelitis or traumatic disorders must be ruled out
with the help of CFS fluid analysis, viral titers and
radiographs.
Serologic testing for B. burgdorfen' antibodies
can be very helpful in confirming LD. Both IFA
and ELISA tests are available. False negative find-
ings can occur, especially early in the clinical course
and some cross reactivity with Leptospira organisms
may result in false positives. For this reason most
labs consider only titers greater than or equal to
1:64 to be indicative of LD. Since some normal
horses have positive titers in endemic areas,
serology alone does not confirm the diagnosis.
Demonstration of a rising titer from paired samples
obtained during clinical disease, plus good
response to therapy are necessary to make a defini-
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tive diagnosis.
Spirochetes can be identified on dark field
microscopy or by culturing from blood, synovial
fluid or urine. Timing and handling of samples
is critical and these procedures are usually not suc-
cessful. Histopathologic findings from kidney, eye,
stomach, reproductive tract, synovium and brain
may show lymphocyte and plasma cell infiltrates.
Krajian silverstain can be used to visualize
spirochetes in the anterior chamber of the eye. 16
Direct IFA should be used on brain tissue from
animals suspected of B. burgd9rferi infection. 19
Treatment and Prevention
Horses have been successfully treated with
antibiotics and non-steroidal anti-inflammatories.
Most commonly used are tetracycline, ampicillin
or procaine penicillin G for 10-14 days. Phenyl-
butazone may be given concurrently. This therapy
usually results in abatement of the clinical signs,
although a recurrent episode a few months after
therapy has been reported in one case. 34 It is
unclear if this therapy completely clears the infec-
tion or if a carrier state may be created. It is
currently presumed that a latent infection persists
if the antibody titer remains high for a year or
more. This may be difficult to distinguish from
titers resulting from repeated exposure in endemic
areas.
Prevention relies on insect control and avoiding
endemic areas. The pattern of clinical disease in
the horse is still unclear but seems to parallel those
of the human. Therefore, any horse with undiag-
nosed disorders involving joints, heart, the nervous
system, eyes, abortions or fetal anomalies should
be considered a suspect for Lyme Disease.
Lyme Disease in Cattle
Lyme disease has recently been reported in
cattle. In a report submitted by Burgess et aI, a
heifer with LD had " ... chronic weight loss,
bilateral distension of the carpal joints, lameness,
and inability to rise without aid' , .20 Investigators
suggest that deer mice may playa vital role in
transmission of this disease, since these mice are
frequent habitors of barns. For this reason, grain
should be stored so that it cannot be contaminat-
ed by the urine of these mice.
Diagnosis
Histopathologic examination of heart, kidney,
lung, and liver has been used to diagnose LD in
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cattle. Lymphocytes, plasma cells, and eosinophils
were seen in cardiac and renal tissue of a cow
diagnosed with LD. Immunofluorescent evaluation
of liver and lung has aided in visualizing B.
burgdorferi spirochetes. IFA and ELISA serologic
titers have been particularly useful in diagnosis.
It is possible to find positive titers to B. burgdorferi
in serum, synovial fluid, and milk.
Treatment and Prevention
At this time, there have been no reports of con-
trolled studies on treatment in the bovine.
Conclusion
Throu~hout the years, the numbers of cases of
Lyme Di;ease have been on the rise. There are cur-
rently so many human cases reported that Schwan
and Burgdorfer from the National Institute of
Allergy and Infectious Disease have claimed LD
to be " ... the most prevalent human arthropod-
borne disease in this country." Animal cases ofLD
are just beginning to be recorded. Dogs and horses
are the most extensively studied domestic animals
infected with the disease. Recently, cattle have
been added to the list.
Despite all the incoming data little is known
about the disease. There have been a few reports
of inconsistencies in the questions about the role
of Ixodes tick as the primary vector. The exact
pathogenesis of the disease is not known.
Additionally, diagnostic procedures and tests
need to be refined to adequately diagnose LD.
Direct staining, phase contrast dark field micro-
scopy, and isolation techniques are not sensitive
tests. Even though the ELISA and IFA test results
have a higher yield, the results are not always
absolute. The urine test, which is currently being
developed, may help improve some of the incon-
sistencies in diagnosis.
The paucity of diagnostic tools may allow LD
to be overlooked. Exposure to a tick infested area,
knowledge of a tick bite, and clinical signs are use-
ful bits of information. The clinician can guard
against an oversight by being observant, ruling out
other diseases and making maximum use of avail-
able diagnostic tests available.
The history of exposure to a tick-infested area,
knowledge of tick bites, or clinical signs consistent
with LD should alert the clinician to the possibil-
ity of this tick- borne disease.
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